Glycoprotein VI deficiency
|
0.600 |
GermlineCausalMutation
|
disease |
ORPHANET |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Absence of collagen-induced platelet activation caused by compound heterozygous GPVI mutations.
|
19549989 |
2009 |
Septicemia
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Additionally, patients admitted to a paediatric intensive care unit (ICU) (<i>n</i> = 73) with an initial diagnosis of sepsis were recruited and their GPVI haplotypes determined.
|
30597490 |
2019 |
Sepsis
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Additionally, patients admitted to a paediatric intensive care unit (ICU) (<i>n</i> = 73) with an initial diagnosis of sepsis were recruited and their GPVI haplotypes determined.
|
30597490 |
2019 |
Myocardial Infarction
|
0.100 |
Biomarker
|
disease |
BEFREE |
Also, treatment of mice undergoing experimental myocardial infarction with αCD133-GPVI-labeled progenitor cells reduces infarction size and preserves myocardial function.
|
22448969 |
2012 |
Blood Coagulation Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Although Btk plays an important role in platelet signalling, increased bleeding tendency in patients on ibrutinib is more complex than Btk inhibition alone and is because of several antiplatelet mechanisms, namely inhibition of Btk and Tec kinases, which play a key role in platelet activation downstream of the collagen GPVI and Glycoprotein Ib.
|
29995658 |
2018 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
An adenine insertion in exon 6 of human GP6 generates a truncated protein associated with a bleeding disorder in four Chilean families.
|
23815599 |
2013 |
Acquired platelet disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Anti-GPVI-associated ITP: an acquired platelet disorder caused by autoantibody-mediated clearance of the GPVI/FcRgamma-chain complex from the human platelet surface.
|
15150079 |
2004 |
Arteriosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Because CD40L is a potent platelet-derived cytokine that is involved in thrombosis and atherosclerosis, we evaluated the effect of GPVI-mediated release of CD40L on activation of endothelial cells.
|
15277394 |
2004 |
Atherosclerosis
|
0.010 |
Biomarker
|
disease |
BEFREE |
Because CD40L is a potent platelet-derived cytokine that is involved in thrombosis and atherosclerosis, we evaluated the effect of GPVI-mediated release of CD40L on activation of endothelial cells.
|
15277394 |
2004 |
Glycoprotein VI deficiency
|
0.600 |
Biomarker
|
disease |
CLINGEN |
Cloning, characterization, and functional studies of human and mouse glycoprotein VI: a platelet-specific collagen receptor from the immunoglobulin superfamily.
|
10961879 |
2000 |
Blood Protein Measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Co-regulatory networks of human serum proteins link genetics to disease.
|
30072576 |
2018 |
Blood Coagulation Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Collagen III has two major hemostasis domains, with binding motifs for von Willebrand factor, α2β1 integrin, platelet binding octapeptide and glycoprotein VI, consistent with the bleeding tendency observed with COL3A1 disease-causing sequence variants.
|
28704418 |
2017 |
Blood Coagulation Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Complete or partial deficiency of GPVI in humans is a rare condition presenting as a mild bleeding disorder.
|
23815599 |
2013 |
von Willebrand Disease, Type 1
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Considering the recent suggestion that platelet membrane glycoprotein polymorphisms (PltGPs) may play a role as modulators of thromboembolic or haemorrhagic diseases, we investigated the role of different PltGPs and GPVI content in the clinical expression of patients with VWD type 1.The diagnosis of VWD (n = 76) was based on laboratory findings (VWF:Ag, VWF:RCo, VWF:CB, FVIII:C, and multimer analysis), family and personal history of bleeding.
|
14652648 |
2003 |
Cardiovascular Diseases
|
0.030 |
GeneticVariation
|
group |
BEFREE |
Contradictory results have been published on the effects of T13254C (rs1613662), which distinguishes the two major isoforms of GP6, the gene encoding the platelet receptor glycoprotein VI, on platelet function and the risk of cardiovascular disease.
|
20723028 |
2010 |
Coronary heart disease
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
|
27848272 |
2017 |
Coronary Artery Disease
|
0.040 |
AlteredExpression
|
disease |
BEFREE |
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
|
27848272 |
2017 |
Coronary Arteriosclerosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
Decreased levels of platelet-derived soluble glycoprotein VI detected prior to the first diagnosis of coronary artery disease in HIV-positive individuals.
|
27848272 |
2017 |
Diabetic Retinopathy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Diabetes duration may modify the association between genetic variation in the glycoprotein Ia subunit of the platelet collagen receptor and risk of severe diabetic retinopathy: a working hypothesis.
|
12540964 |
2003 |
Coronary heart disease
|
0.040 |
GeneticVariation
|
disease |
LHGDN |
Effect of genetic variations in platelet glycoproteins Ibalpha and VI on the risk for coronary heart disease events in postmenopausal women taking hormone therapy.
|
17105818 |
2007 |
Diabetes
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Fc receptor expression correlated with GPVI expression and was found to be independently associated with diabetes (r = 0.529, P < 0.001).
|
15277394 |
2004 |
Diabetes Mellitus
|
0.030 |
AlteredExpression
|
group |
BEFREE |
Fc receptor expression correlated with GPVI expression and was found to be independently associated with diabetes (r = 0.529, P < 0.001).
|
15277394 |
2004 |
Heparin-induced thrombocytopenia
|
0.010 |
Biomarker
|
disease |
BEFREE |
Finally, we present some new data investigating whether levels of the extracellular ligand-binding region of platelet glycoprotein VI which is rapidly shed upon engagement of platelet FcγRIIa by autoantibodies, can report on the presence of pathological anti-heparin/platelet factor 4 immune complexes and thus identify patients with pathological autoantibodies who are at the greatest risk of developing life-threatening thrombosis in the setting of heparin-induced thrombocytopenia.
|
26497525 |
2015 |